Clinical trial
Endothelial Microparticules as Biomarker of Antibody-mediated Rejection in Kidney Transplantation
NCT03098238 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Endothelial Microparticules as Biomarker of Antibody-mediated Rejection in Kidney Transplantation
- Lead sponsor
- University Hospital, Montpellier
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2017
- Completion date
- June 4, 2020
- Enrollment
- 249 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
renal transplantation